Skip to main content

Table 1 Demographic and clinical characteristics of all new TB patients who had an unsuccessful TB treatment outcome, stratified by HIV status

From: Unsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa

Variable

TB-HIV Co-infected

n = 9991

n (%)

95% confidence interval)

HIV negative

n = 2089

n (%)

95% confidence interval

HIV status not recorded

n = 3192

n (%)

95% confidence interval

Total

n = 15,272

n (%)

95% confidence interval

Sex

 Male

5276 (52.8)

51.8-53.8

1444 (69.1)

67.1-71.1

1924 (60.3)

58.6-62.0

8644 (56.6)

55.8-57.4

 Female

4715 (47.2)

46.2-48.2

645 (30.9)

28.9-32.6

1268 (39.7)

38.2-41.4

6628 (43.4)

42.6-44.2

Age group

 15-24

816 (8.2)

7.6-8.7

318 (15.2)

13.7-16.8

268 (8.4)

7.4-9.4

1402 (9.2)

8.7-9.6

 25-34

3215 (32.2)

31.3-33.1

342 (16.4)

14.8-17.9

837 (26.2)

24.7-27.7

4394 (28.8)

28.1-29.5

 35-44

3287 (32.9)

32.0-33.8

322 (15.4)

13.9-167.0

805 (25.2)

23.7-26.7

4414 (28.9)

28.2-29.6

 45-54

1903 (19.0)

18.3-19.8

395 (18.9)

17.2-20.6

685 (21.5)

20.0-22.9

2983 (19.5)

18.9-20.2

 55-64

643 (6.4)

5.9-6.9

389 (18.6)

16.9-20.3

362 (11.3)

10.2-21.4

1394 (9.1)

8.7-9.6

 ≥65

127 (1.3)

 

323 (15.5)

13.9-17.0

235 (7.4)

6.5-8.3

685 (4.5)

4.1-4.8

District

 A

1786 (17.9)

17.1-18.6

3 66 (17.5)

15.9-19.2

448 (14.0)

12.8-15.2

2600 (17.0)

16.4-17.6

 B

2449 (24.5)

23.7-25.4

471 (22.5)

20.8-24.3

482 (15.1)

13.9-16.3

3402 (22.3)

21.6-22.9

 C

2649 (26.5)

25.6-27.4

517 (24.8)

22.8.9-26.6

1007 (31.6)

29.9-33.1

4173 (27.3)

26.728.0

 D

2620 (26.2)

25.4-27.1

540 (25.9)

234.0-27.7

1104 (34.6)

32.9-36.2

4264 (27.9)

27.2-28.6

 E

487 (4.9)

4.4-5.3

195 (9.3)

8.1-10.6

151 (4.7)

4.0-5.5

833 (5.5)

5.1-5.8

Disease classification

 Both

187 (1.9)

1.6-2.1

26 (1.2)

0.7-1.7

42 (1.3)

0.9-1.7

255 (1.7)

1.5-1.9

 Extra-pulmonary

2135 (21.4)

20.6-22.2

307 (14.7)

13.2-16.2

832 (26.1)

24.5-27.6

3274 (21.4)

20.8-22.1

 Pulmonary

7669 (76.7)

75.9-77.6

1756 (84.1)

82.5-85.6

2318 (72.6)

71.0-74.2

11,743 (76.9)

76.2-77.6

Pre-treatment sputum smear resulta

 Sputum smear positive

4346 (61.2)

60.0-62.3

1083 (65.5)

63.2-67.8

1196 (67.4)

65.2-69.6

6625 (62.9)

62.0-63.8

 Sputum smear negative

2760 (38.8)

37.7-40.0

571 (34.5)

32.2-36.8

578 (32.6)

30.3-34.8

3909 (37.1)

36.2-38.0

Treatment delayb

 0-14 days

4772 (83.0)

82.1-84.1

1166 (85.3)

83.4-87.2

1251 (85.5)

83.7-87.3

7189 (83.8)

83.1-84.6

 15+ days

974 (17.0)

16.0-17.9

201 (14.7)

12.8-16.5

212 (14.5)

12.7-16.3

1387 (16.2)

15.4-17.0

On ART/CPT

 Neither on ART nor CPT only

1292 (12.9)

12.3-13.6

NA

NA

NA

NA

1292 (12.9)

12.3-13.6

 On ART only

367 (3.7)

3.3-4.0

NA

NA

NA

NA

367 (3.7)

3.3-4.0

 On CPT only

4202 (42.1)

41.1-43.0

NA

NA

NA

NA

4202 (42.1)

41.1-43.0

 On both ART and CPT

4130 (41.3)

40.4-42.3

NA

NA

NA

NA

4130 (41.3)

40.4-42.3

CD4 count

 1-200

4211 (75.9)

74.7-77.0

NA

NA

NA

NA

4211 (75.9)

74.7-77.0

 201-350

839 (15.1)

14.2-16.1

NA

NA

NA

NA

839 (15.1)

14.2-16.1

 351+

502 (9.0)

8.2-9.8

NA

NA

NA

NA

502 (9.0)

8.2-9.8

  1. NA not applicable.
  2. aHIV-positive n = 7106, HIV-negative n = 1654, HIV status unknown n = 1774
  3. bHIV-positive n = 5746, HIV-negative n = 1367, HIV status unknown n = 1463